Gregg Hymowitz - Mar 4, 2024 Form 4 Insider Report for FLYEXCLUSIVE INC. (FLYX)

Signature
/s/ Gregg S. Hymowitz
Stock symbol
FLYX
Transactions as of
Mar 4, 2024
Transactions value $
$25,000,000
Form type
4
Date filed
3/6/2024, 06:51 PM
Previous filing
Dec 29, 2023
Next filing
Aug 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLYX Series A Non-Convertible Redeemable Preferred Stock Purchase $25M +25K $1,000.00* 25K Mar 4, 2024 See Footnote F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLYX Warrant (Right to Buy) Purchase +1 1 Mar 4, 2024 Class A common stock, ("Common Stock") $0.01 See Footnote F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 4, 2024, EnTrust Emerald (Cayman) LP purchased 25,000 shares of Series A Non-Convertible Redeemed Preferred Stock, par value $0,0001 per share, together with a warrant to purchase a number of a shares of Common Stock equal to 1.5% of the Company's outstanding shares of Common Stock on a fully diluted basis as of the trading day prior to the delivery of the exercise notice (subject to the cap and other limitations discussed in Note 3, below), for a total purchase price of $25,000,000.
F2 Held by EnTrust Emerald (Cayman) LP. Gregg Hymowitz serves as the Founder and Chief Executive Officer of EnTrust Global, an affiliate of which serves as the general partner of EnTrust Emerald (Cayman) LP, and may be deemed to be the beneficial owner of such shares held by EnTrust Emerald (Cayman) LP. Each such person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.
F3 The warrant may be exercised in whole or in part during the exercise period with respect to a number of a shares of Common Stock equal to 1.5% of the Company's outstanding shares of Common Stock on a fully diluted basis as of the trading day immediately prior to the date of delivery of a notice of exercise. The warrant is not exercisable until the second anniversary of its issuance at which time it may be exercised for up to one half of the shares. The warrant may be exercised for the remaining shares on and after the third anniversary of its issuance. The warrant may not be exercised for a number of shares having an aggregate value in excess of $11,250,000, calculated in accordance with the terms of the warrant.